{"preliminary_commentary":{"by_channel":{"x_thread":11},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02629458\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[],"indication":"peripheral stage I non-small cell lung cancer","name":"SABRTooth","nct_id":"NCT02629458","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=sabrtooth-nct02629458. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"SABRTOOTHv1","arms":[{"description":null,"label":"Patients requiring surgery","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2017-01-31","type":"ACTUAL"},"conditions":["Oncology"],"enrollment":{"count":54,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Treatment by Surgical resection","otherNames":[],"type":"PROCEDURE"},{"name":"Stereotactic Ablative Radiotherapy (SABR)","otherNames":[],"type":"PROCEDURE"}],"last_update":"2019-07-12","lead_sponsor":"The Leeds Teaching Hospitals NHS Trust","official_title":"A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy (SABR) With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer (NSCLC) cOnsidered Higher Risk of Complications From Surgical Resection","overall_status":"COMPLETED","phases":["NA"],"primary_completion_date":{"date":"2017-01-31","type":"ACTUAL"},"primary_outcomes":[{"measure":"Acheivment of a 'steady state' of recruitment.","timeFrame":"Rate of recruitment over months 7 to 21."}],"references":[{"citation":"Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T. Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy. Clin Lung Cancer. 2021 May;22(3):e342-e359. doi: 10.1016/j.cllc.2020.05.024. Epub 2020 Jun 2.","pmid":"32736936","type":"DERIVED"},{"citation":"Franks KN, McParland L, Webster J, Baldwin DR, Sebag-Montefiore D, Evison M, Booton R, Faivre-Finn C, Naidu B, Ferguson J, Peedell C, Callister MEJ, Kennedy M, Hewison J, Bestall J, Gregory WM, Hall P, Collinson F, Olivier C, Naylor R, Bell S, Allen P, Sloss A, Snee M. SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection. Eur Respir J. 2020 Nov 12;56(5):2000118. doi: 10.1183/13993003.00118-2020. Print 2020 Nov.","pmid":"32616595","type":"DERIVED"}],"start_date":{"date":"2015-07-01","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection","url":"https://clinicaltrials.gov/study/NCT02629458"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/sabrtooth-nct02629458"}